» Articles » PMID: 25750564

Clinical and Microbiological Features of Providencia Bacteremia: Experience at a Tertiary Care Hospital

Overview
Specialty General Medicine
Date 2015 Mar 10
PMID 25750564
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background/aims: Providencia species frequently colonize urinary catheters and cause urinary tract infections (UTIs); however, bacteremia is uncommon and not well understood. We investigated the clinical features of Providencia bacteremia and the antibiotic susceptibility of Providencia species.

Methods: We identified cases of Providencia bacteremia from May 2001 to April 2013 at a tertiary care hospital. The medical records of pertinent patients were reviewed.

Results: Fourteen cases of Providencia bacteremia occurred; the incidence rate was 0.41 per 10,000 admissions. The median age of the patients was 64.5 years. Eleven cases (78.6%) were nosocomial infections and nine cases (64.3%) were polymicrobial bacteremia. The most common underlying conditions were cerebrovascular/neurologic disease (n = 10) and an indwelling urinary catheter (n = 10, 71.4%). A UTI was the most common source of bacteremia (n = 5, 35.7%). The overall mortality rate was 29% (n = 4); in each case, death occurred within 4 days of the onset of bacteremia. Primary bacteremia was more fatal than other types of bacteremia (mortality rate, 75% [3/4] vs. 10% [1/10], p = 0.041). The underlying disease severity, Acute Physiologic and Chronic Health Evaluation II scores, and Pitt bacteremia scores were significantly higher in nonsurvivors (p = 0.016, p =0.004, and p = 0.002, respectively). Susceptibility to cefepime, imipenem, and piperacillin/tazobactam was noted in 100%, 86%, and 86% of the isolates, respectively.

Conclusions: Providencia bacteremia occurred frequently in elderly patients with cerebrovascular or neurologic disease. Although Providencia bacteremia is uncommon, it can be rapidly fatal and polymicrobial. These characteristics suggest that the selection of appropriate antibiotic therapy could be complicated in Providencia bacteremia.

Citing Articles

Clinical and Drug Resistance Characteristics of Infections.

Malviya M, Kale-Pradhan P, Coyle M, Giuliano C, Johnson L Microorganisms. 2024; 12(10).

PMID: 39458394 PMC: 11510300. DOI: 10.3390/microorganisms12102085.


Population-based study of group bloodstream infections.

Laupland K, Pasquill K, Steele L, Parfitt E J Assoc Med Microbiol Infect Dis Can. 2024; 8(2):134-140.

PMID: 38250289 PMC: 10795700. DOI: 10.3138/jammi-2022-0038.


Antimicrobial Resistance in Papua New Guinea: A Narrative Scoping Review.

Page B, Adiunegiya S Antibiotics (Basel). 2023; 12(12).

PMID: 38136713 PMC: 10741211. DOI: 10.3390/antibiotics12121679.


Detection of NDM-1 and OXA-10 Co-Producing Clinical Isolate.

Li Y, Shao K, Cai R, Liu Y, Liu X, Ni F Infect Drug Resist. 2023; 16:5319-5328.

PMID: 37601562 PMC: 10439778. DOI: 10.2147/IDR.S418131.


infection complicating cranial surgery: illustrative cases.

Sapkota S, Karn M, Regmi S, Thapa S, Miya F, Yonghang S J Neurosurg Case Lessons. 2022; 2(8):CASE21318.

PMID: 35855091 PMC: 9265186. DOI: 10.3171/CASE21318.


References
1.
OHara C, Brenner F, Miller J . Classification, identification, and clinical significance of Proteus, Providencia, and Morganella. Clin Microbiol Rev. 2000; 13(4):534-46. PMC: 88947. DOI: 10.1128/CMR.13.4.534. View

2.
Zavascki A, Carvalhaes C, da Silva G, Tavares Soares S, de Alcantara L, Elias L . Outbreak of carbapenem-resistant Providencia stuartii in an intensive care unit. Infect Control Hosp Epidemiol. 2012; 33(6):627-30. DOI: 10.1086/665730. View

3.
Stickler D . Susceptibility of antibiotic-resistant gram-negative bacteria to biocides: a perspective from the study of catheter biofilms. Symp Ser Soc Appl Microbiol. 2002; (31):163S-170S. View

4.
Kim B, Kim N, Kim M, Kim Y, Woo J, Ryu J . Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000). Scand J Infect Dis. 2003; 35(2):98-103. DOI: 10.1080/0036554021000027015. View

5.
Tumbarello M, Citton R, Spanu T, Sanguinetti M, Romano L, Fadda G . ESBL-producing multidrug-resistant Providencia stuartii infections in a university hospital. J Antimicrob Chemother. 2003; 53(2):277-82. DOI: 10.1093/jac/dkh047. View